Society for Translational Oncology Inc.
Society for Translational Oncology Inc.
Want to make a donation using Daffy?
Lower your income taxes with a charitable deduction this year when you donate to this non-profit via Daffy.
Do you work for Society for Translational Oncology Inc.? Learn more here.
About this organization
Mission
Promote education of oncologists by providing publications, meetings, and enduring materials that serve to shorten the "translational gap" between discovery and deployment of new treatments to improve patient care. The foundation of STO's educational interventions is the improvement of physician competencies and strategies for the screening, prevention, diagnosis, treatment, and management of patients with cancer; and enhancement of performance-in-practice. STO is a non-profit, professional association dedicated to the continued education of its members and cancer caregivers, and to improvement in the quality and safety of care for the patient with cancer. The educational content of STO focuses on medical, radiation, and surgical oncology. Education is disseminated through live conferences, workshops, internet webcasts and journal-based articles. Its audience is comprised of medical, radiation and surgical oncologists, nurses, researchers and other health professionals.
About
STO's purpose is to provide a high-quality educational program that improves health care by bringing information on the latest treatments for cancer as quickly as possible to physicians everywhere. This makes cutting-edge care more widely available than if the information was only known at the large research medical centers.The corporation carries out its educational program in connection with a medical publication called 'The Oncologist' to physicians who join STO as members. Membership is open to any oncologist or anyone otherwise professionally involved with oncology. 'The Oncologist' is an international print and online peer-reviewed journal devoted to medical and practice issues for those entrusted with the care of cancer patients. Now in the nineteeth year of publication, 'The Oncologist' is recognized in the field as the premier medical journal for oncology. The journal is published at least 12 times per year and approximately 20% of the articles are selected to be the basis for a Continuing Medical Education ("CME") program. The author of selected peer-accepted articles and the editors of 'The Oncologist' prepare a web-based education program that provides study guides, test the physicians' comprehension of the article and reinforces the medical information in the article. By completing an online questionnaire, the physician can receive CME credits. In the past, 'The Oncologist' CME online program has been sponsored with the National Institutes of Health ("NIH") and with the University of North Carolina at Chapel Hill ("UNC"). Both NIH and UNC were accredited providers of CME. STO was provisionally accredited by the Accreditation Council for Continuing Medical Education ("ACCME") as a provider of CME for physicians in 2008. In 2009 the STO began the self-study portion of the reaccreditation process which was completed in late 2010. In 2011, STO was awarded full accreditation by the ACCME for 4 years. This process is time-consuming and work-intensive. The yearlong project includes a thorough examination and review of the quality of the educational materials being offered.By making the articles available via the internet and mobile apps, physicians in all parts of the country and globally learn about the newest treatments for cancer and obtain CME credits. Thus, STO is providing up-to-date information to physicians in communities where there is not a cancer center. This outreach improves the quality of care available to the many cancer patients who are treated outside the major medical research centers. STO conducts follow-up with the physicians who complete the educational programs to learn if the information was of use to the physician and how the physician implemented the materials into practice.In October 2013, STO endeavored to conduct its fourth live annual meeting in Amsterdam, Netherlands. The Fourth Annual STO meeting was jointly sponsored by Vanderbilt University Medical Center and the Society for Translational Oncology and in partnership with STO's official journal, 'The Oncologist.'This unique conference was attended by over 100 physician-scientists and clinical investigators. It offered an intimate look at some of the best clinical research and its application to clinical practice, and in local biotechs and industry. Speakers covered a range of topics from basic research to cutting-edge clinical trials.
Additional Non-Profits in the area
By donating on this page you are making an irrevocable contribution to Daffy Charitable Fund, a 501(c)(3) public charity, and a subsequent donation recommendation to the charity listed above, subject to our Member Agreement. Contributions are generally eligible for a charitable tax-deduction and a yearly consolidated receipt will be provided by Daffy. Processing fees may be applied and will reduce the value available to send to the end charity. The recipient organizations have not provided permission for this listing and have not reviewed the content.
Donations to organizations are distributed as soon as the donation is approved and the funds are available. In the rare event that Daffy is unable to fulfill the donation request to this charity, you will be notified and given the opportunity to choose another charity. This may occur if the charity is unresponsive or if the charity is no longer in good standing with regulatory authorities.